Bacterial resistance to CRISPR-Cas antimicrobials
Abstract In the age of antibiotic resistance and precise microbiome engineering, CRISPR-Cas antimicrobials promise to have a substantial impact on the way we treat diseases in the future. However, the efficacy of these antimicrobials and their mechanisms of resistance remain to be elucidated. We sys...
Main Authors: | Ruben V. Uribe, Christin Rathmer, Leonie Johanna Jahn, Mostafa Mostafa Hashim Ellabaan, Simone S. Li, Morten Otto Alexander Sommer |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-08-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-96735-4 |
Similar Items
-
Dominant resistance and negative epistasis can limit the co-selection of de novo resistance mutations and antibiotic resistance genes
by: Andreas Porse, et al.
Published: (2020-03-01) -
Adaptive Laboratory Evolution of Antibiotic Resistance Using Different Selection Regimes Lead to Similar Phenotypes and Genotypes
by: Leonie J. Jahn, et al.
Published: (2017-05-01) -
Forecasting the dissemination of antibiotic resistance genes across bacterial genomes
by: Mostafa M. H. Ellabaan, et al.
Published: (2021-04-01) -
Harnessing the CRISPR-Cas Systems to Combat Antimicrobial Resistance
by: Cheng Duan, et al.
Published: (2021-08-01) -
Enlarging the Toolbox Against Antimicrobial Resistance: Aptamers and CRISPR-Cas
by: Higor Sette Pereira, et al.
Published: (2021-02-01)